Amber Salzman
Chief Executive Officer Epicrispr Biotechnologies
Seminars
Thursday 26th March 2026
Designing Smarter Trials with External Controls & the Use of Digital Twins
11:40 am
- Investigating how external controls and natural history data can support trial design when internal controls are not feasible
- Evaluating strategies for rare disease trials where there is variability of progression which needs to be quantified
- Understanding how trial design choices impact speed, cost, and regulatory success across biotech and pharma settings
